Why Shenzhen为什么深圳

Shenzhen,
the closest first-tier Chinese gateway to Malaysia,
and a world-class city with dense healthcare, technology and innovation.
深圳,最靠近马来西亚的中国一线门户,
也是医疗、科技与创新高度集中的世界级都市。

Atlas chose Shenzhen for more than its medical resources. For Malaysian clients, Shenzhen combines a South China location, direct air access, major-city economic scale, dense medical capacity and a world-leading technology and innovation ecosystem. It is a practical first clinical base for Atlas Assessments and integrated review.Atlas 选择深圳,不只是因为医疗资源。对马来西亚客户而言,深圳同时具备地处华南、直飞便利、有着巨大的城市经济体量和
高密度医疗承载力,以及全球领先的科技创新生态。它适合作为 Atlas 健康产品与医生整合解读的第一临床基地。

Cross-Border Practicality跨境便利

A short direct flight,
suitable for completing a concentrated assessment visit.
短距离直飞,适合集中完成检查行程。

Economic Scale经济体量

The scale of a major global-city economy.一座城市,巨大的经济体量。

Using a consistent 2025 nominal comparison basis, Shenzhen’s GDP was about US$538.9B, above Malaysia’s approximately US$472.6B. GDP is not a proxy for healthcare quality, but it shows the economic base supporting dense concentrations of talent, technology, infrastructure and medical resources.按统一的 2025 年名义口径换算,深圳 GDP 约 US$538.9B,高于马来西亚全国约 US$472.6B。
GDP 不等于医疗质量,但它说明这座城市拥有支撑高密度人才、科技、基础设施与医疗资源的经济底座。

Metric指标 Shenzhen深圳 Malaysia马来西亚
Population人口 18.25M | 2025 34.10M | 2024
Nominal GDP名义 GDP US$538.9B | 2025 US$472.6B | 2025
GDP per Capita人均 GDP US$29,741 | 2025 US$13,805 | 2025

Shenzhen figures from the Shenzhen Statistics Bureau (2025 GDP RMB 3,873.180B; GDP per capita RMB 213,763; year-end resident population 18.2485M). Malaysia figures from DOSM (2025 nominal GDP about RM 2.023 trillion; nominal GDP per capita RM 59,099.5). Converted at the 2025 annual average rates published by the US Federal Reserve: US$1 = RMB 7.1875, US$1 = RM 4.2809.深圳数据引自深圳市统计局(2025 年 GDP 38,731.80 亿元人民币,人均 GDP 213,763 元,年末常住人口 1,824.85 万)。马来西亚数据引自 DOSM(2025 年名义 GDP 约 RM2.023 万亿,名义人均 GDP RM59,099.5)。美元按美国 Federal Reserve 公布的 2025 年全年平均汇率换算:US$1 = RMB 7.1875,US$1 = RM 4.2809。

Innovation Ecosystem创新生态

World No. 1 innovation cluster.全球第一创新集群。

In the WIPO Global Innovation Index 2025, the Shenzhen-Hong Kong-Guangzhou cluster ranked No. 1 worldwide. For Atlas, this concentration of innovation matters because healthspan medicine increasingly sits at the intersection of clinical medicine, diagnostics, biotechnology, genomics, cells, data and medical technology.在 WIPO《全球创新指数 2025》中,“深圳-香港-广州”创新集群位列全球第一。对 Atlas 而言,这种创新密度非常重要,因为健康寿命医学越来越处在临床医学、检测、生物技术、基因、细胞、数据与医疗科技的交叉区域。

Clinical medicine临床医学 Diagnostics检测 Biotechnology生物技术 Genomics基因 Cells细胞 Data数据 Medical technology医疗科技

Medical Capacity & Health Outcomes医疗承载力与健康结果

Large high-quality medical capacity concentrated within one city.巨量优质医疗承载力,集中在同一座城市。

Metric指标 Shenzhen深圳 Malaysia马来西亚
Hospital Beds其中医院病床 86,035 | 2025 71,968 | 2024*
Hospital Beds per 1,000医院病床 / 千人 4.71 | 2025 2.11 | 2024*
Life Expectancy预期寿命 84.53 yrs | 2025 75.3 yrs | 2025

Medical-bed classification scopes are not fully identical, so these figures are used to understand capacity and density rather than to directly compare quality of care. What matters is the concentration of hospitals, beds, laboratories, imaging, specialties and long-term management resources within one city.医疗床位分类范围并不完全相同,因此这些数字用于理解承载规模与密度,而不用于直接比较医疗质量。
真正重要的是医院、床位、检验、影像、专科与长期管理资源集中在同一座城市。

*Shenzhen 2025 statistical communiqué: 6,011 health institutions, 171 hospitals and 92,327 institutional beds, of which 86,035 are hospital beds, against a year-end resident population of 18.2485M. *Malaysia figures are as at 31 December 2024, per Health Facts 2025.*深圳 2025 年统计公报:年末共有 6,011 个医疗卫生机构、171 家医院、92,327 张卫生机构床位,其中医院病床 86,035 张。按年末常住人口 1,824.85 万计算。*马来西亚数据为截至 2024 年 12 月 31 日口径,引自 Health Facts 2025。

Life expectancy: Shenzhen 84.53 years for 2025 as stated in the city’s official 15th Five-Year Plan; Malaysia 75.3 years at birth for 2025 from the DOSM 2025 Abridged Life Tables.预期寿命:深圳 2025 年人均预期寿命 84.53 岁,引自深圳官方“十五五”规划;马来西亚 2025 年出生人口平均预期寿命 75.3 岁,引自 DOSM《2025 Abridged Life Tables》。

Cross-Regional Medical Capacity跨区域医疗承接能力

An increasingly mature capacity to receive patients
from other regions and from overseas.
越来越成熟的跨区域与国际患者承接能力。

97

International Medical-Service Institutions | 2025国际化医疗服务机构|2025

~20%

YoY Growth in Overseas Patient Visits境外患者就诊量同比增长

11.6%

Share of Inpatients from Outside Shenzhen市外患者住院占比

1000+

Community Health-Service Institutions社区健康服务机构

Shenzhen in the Atlas Pathway深圳在 Atlas 路径中的位置

A clinical base, a bridge to the next step.临床基地,通往下一步路径的桥梁

MALAYSIA / SOUTHEAST ASIA马来西亚 / 东南亚

Existing doctors, records and healthcare relationships已有医生、资料和医疗关系

SHENZHEN / LUOHU深圳 / 罗湖

Atlas Immune Optimization + Atlas Healthspan Assessment, with integrated physician reviewAtlas 免疫优化方案 + Atlas 健康寿命评估,医院医生整合解读

THE WAY FORWARD未来方向

Helping clients define their next health pathway帮助客人定义下一步健康路径